Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex.

Saved in:
Bibliographic Details
Title: Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex.
Authors: Gillis N; Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Colin-Leitzinger C; Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Tang YH; Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Otterstatter M; The Emmes Company, Rockville, Maryland, USA., Sherman S; The Emmes Company, Rockville, Maryland, USA., Zhang L; Department of Hematopathology and Laboratory Medicine, Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Moscinski LC; Department of Hematopathology and Laboratory Medicine, Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Walker ME; Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Painter JS; Tissue Core, Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Abel GA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Al Baghdadi T; Department of Hematology and Oncology, Trinity Health IHA Medical Group, Michigan Cancer Research Consortium, Ypsilanti, Michigan, USA., Deeg HJ; Fred Hutchinson Cancer Center, Seattle, Washington, University of Washington, Seattle, Washington, USA.; University of Washington, Seattle, Washington, USA., Foran JM; Division of Hematology & Medical Oncology, Mayo Clinic Comprehensive Cancer Center, Jacksonville, Florida, USA., Gore SD; Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA., Harrington AM; Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Kroft SH; Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Liu JJ; Illinois CancerCare, Heartland NCORP, Peoria, Illinois, USA., Saber W; Division of Hematology/Oncology, Department of Medicine, CIBMTR Milwaukee, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Virani S; Vince Lombardi Cancer Clinic, Aurora Health Care, Burlington, Wisconsin, USA., Bejar R; Division of Hematology and Oncology, UC San Diego Moores Cancer Center, La Jolla, California, USA., Lindsley RC; Department of Medical Oncology, Division of Hematological Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Padron E; Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Walter MJ; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA., Komrokji R; Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., DeZern AE; Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA., Sekeres MA; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA.
Source: American journal of hematology [Am J Hematol] 2026 Jun; Vol. 101 (6), pp. 1407-1420. Date of Electronic Publication: 2026 Mar 29.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1096-8652
DOI:10.1002/ajh.70279